The city of San Antonio, Texas, currently has 15 active clinical trials seeking participants for Healthy research studies.
A Study of TAK-279 in Adults With or Without Liver Damage
NCT05976321
Recruiting
The main aim of this study is to find out how the body processes 1 dose of TAK-279 (pharmacokinetics) in participants with liver problems compared to participants without liver problems. Other aims are to check for side effects from TAK-279 and to learn how well participants tolerate 1 dose of TAK-279. The participants will need to stay at the clinic for 11 days.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/21/2023
Locations: American Research Corporation - Texas Liver Institute, San Antonio, Texas +1 locations
Conditions: Hepatic Impairment, Healthy Volunteers
Register for Updates
To Study the Oral Bioavailability of a New Combination Formation of Decitabine and Tetrahydrouridine in Healthy Males
NCT05816356
Recruiting
This is an open-label, randomized, single-dose per period, two-period, crossover study to evaluate the relative bioavailability of decitabine and tetrahydrouridine ingested as a modified-release combination formulation compared to THU and decitabine ingested as immediate-release capsules
Gender:
Male
Ages:
Between 18 years and 50 years
Trial Updated:
09/05/2023
Locations: Worldwide Clinical Trails Early Phase Services, San Antonio, Texas
Conditions: Healthy
Register for Updates
Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults
NCT04593784
Recruiting
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ciraparantag for reversal of anticoagulation induced by different anticoagulant drugs in generally healthy adults as measured primarily by an automated coagulometer device.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
07/18/2023
Locations: ICON Early Phase Services, LLC, San Antonio, Texas
Conditions: Healthy
Register for Updates